Electroencephalography

Network functional connectivity analyses based on electroencephalography, or EEG, effectively differentiate between responses to an antidepressant vs. placebo, according to results of a secondary analysis of a randomized clinical trial published in JAMA Psychiatry. Researchers noted that this ability to differentiate may help establish a placebo signature in clinical trials through an alternative direction.

Researchers found that bispectral electroencephalography, or EEG, can predict patient outcomes, including mortality, in older hospitalized patients.